OR WAIT null SECS
July 05, 2017
Samsung BioLogics signs $55.5 million agreement to manufacture tildrakizumab for Sun Pharma.
July 02, 2017
Industry experts discuss the single-use revolution and changes to upstream and downstream processing equipment.
The BIOSTAT STR single-use bioreactor family from Sartorius Stedim Biotech is based on a conventional stirred-tank design.
New ADC therapies must overcome manufacturing challenges to reach market.
As commercial manufacturing considers single-use materials, a look shows how industry moved to the technology.
Biotech-based therapies and a move to single-use processes highlight recent industry changes.
ISPE measures impact of biotechnology and globalization on personalized medicine.
Advancements in cell culture and protein technology have opened the door for new therapies.
Greater transparency and reliability of information are needed in the quality assessments of biosimilars.
June 27, 2017
BIO report measures decade-long investment and acquisition trends for emerging biotech companies.